Skip to main content
Erschienen in: Hernia 3/2008

01.06.2008 | Original Article

Analysis of c-myc, PAI-1 and uPAR in patients with incisional hernias

verfasst von: R. Rosch, M. Binnebösel, K. Junge, P. Lynen-Jansen, P. R. Mertens, U. Klinge, V. Schumpelick

Erschienen in: Hernia | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Disturbed wound healing leading to alterations in collagen composition has been thought to play a key role in the pathogenesis of incisional hernia formation. The aim of the present study was to further characterise the scarring process in such patients.

Methods

Mature skin scars from patients with either primary or recurrent incisional hernias were compared to mature abdominal skin scars from patients without hernias. The distribution of collagen types I and III was analysed using crosspolarisation microscopy. Expression of c-myc—a parameter for cell differentiation and proliferation—and of PAI-1 and uPAR—parameters of the proteolytic cascade in wound healing—were determined by immunohistochemistry.

Results

In agreement with previous studies, decreased collagen I/III ratios were found in patients with incisional hernias. In these patients, c-myc levels were significantly elevated whereas plasminogen activator inhibitor-1 (PAI-1) and urokinase-plasminogen activator receptor (uPAR) levels were only slightly increased. In contrast to controls, a significant correlation between c-myc, PAI-1 and uPAR expression and collagen I/III ratios was found in patients with incisional hernias.

Conclusion

The differential correlation of collagen types and expression of c-myc, PAI-1 and uPAR within the scar tissue might represent a causal factor in incisional hernia formation.
Literatur
1.
Zurück zum Zitat McEntyre RL, Raffensperger JG (1977) Surgical complications of Ehlers-Danlos syndrome in children. J Pediatr Surg 12:531–535PubMedCrossRef McEntyre RL, Raffensperger JG (1977) Surgical complications of Ehlers-Danlos syndrome in children. J Pediatr Surg 12:531–535PubMedCrossRef
2.
Zurück zum Zitat Adye B, Luna G (1998) Incidence of abdominal wall hernia in aortic surgery. Am J Surg 175:400–402PubMed Adye B, Luna G (1998) Incidence of abdominal wall hernia in aortic surgery. Am J Surg 175:400–402PubMed
3.
Zurück zum Zitat Girotto JA, Malaisrie SC, Bulkely G, Manson PN (2000) Recurrent ventral herniation in Ehlers-Danlos syndrome. Plast Reconstr Surg 106:1520–1526PubMedCrossRef Girotto JA, Malaisrie SC, Bulkely G, Manson PN (2000) Recurrent ventral herniation in Ehlers-Danlos syndrome. Plast Reconstr Surg 106:1520–1526PubMedCrossRef
4.
Zurück zum Zitat Augestad KM, Wilsgaard T, Solberg S (2002) Incisional hernia after surgery for abdominal aortic aneurysm. Tidsskr Nor Laegeforen 122:22–24PubMed Augestad KM, Wilsgaard T, Solberg S (2002) Incisional hernia after surgery for abdominal aortic aneurysm. Tidsskr Nor Laegeforen 122:22–24PubMed
5.
Zurück zum Zitat Papadimitriou D, Pitoulias G, Papaziogas B, Koutsias S, Vretzakis G, Argiriadou H, Papaziogas T (2002) Incidence of abdominal wall hernias in patients undergoing aortic surgery for aneurysm or occlusive disease. Vasa 31:111–114PubMedCrossRef Papadimitriou D, Pitoulias G, Papaziogas B, Koutsias S, Vretzakis G, Argiriadou H, Papaziogas T (2002) Incidence of abdominal wall hernias in patients undergoing aortic surgery for aneurysm or occlusive disease. Vasa 31:111–114PubMedCrossRef
6.
Zurück zum Zitat Sorensen LT, Friis E, Jorgensen T, Vennits B, Andersen BR, Rasmussen GI, Kjaergaard J (2002) Smoking is a risk factor for recurrence of groin hernia. World J Surg 26:397–400PubMedCrossRef Sorensen LT, Friis E, Jorgensen T, Vennits B, Andersen BR, Rasmussen GI, Kjaergaard J (2002) Smoking is a risk factor for recurrence of groin hernia. World J Surg 26:397–400PubMedCrossRef
7.
Zurück zum Zitat Sorensen LT, Hemmingsen UB, Kirkeby LT, Kallehave F, Jorgensen LN (2005) Smoking is a risk factor for incisional hernia. Arch Surg 140:119–123PubMedCrossRef Sorensen LT, Hemmingsen UB, Kirkeby LT, Kallehave F, Jorgensen LN (2005) Smoking is a risk factor for incisional hernia. Arch Surg 140:119–123PubMedCrossRef
8.
Zurück zum Zitat Read RC (1970) Attenuation of the rectus sheath in inguinal herniation. Am J Surg 120:610–614PubMedCrossRef Read RC (1970) Attenuation of the rectus sheath in inguinal herniation. Am J Surg 120:610–614PubMedCrossRef
9.
Zurück zum Zitat Bellon JM, Bujan J, Honduvilla NG, Jurado F, Gimeno MJ, Turnay J, Olmo N, Lizarbe MA (1997) Study of biochemical substrate and role of metalloproteinases in fascia transversalis from hernial processes. Eur J Clin Invest 27:510–516PubMedCrossRef Bellon JM, Bujan J, Honduvilla NG, Jurado F, Gimeno MJ, Turnay J, Olmo N, Lizarbe MA (1997) Study of biochemical substrate and role of metalloproteinases in fascia transversalis from hernial processes. Eur J Clin Invest 27:510–516PubMedCrossRef
10.
Zurück zum Zitat Klinge U, Si ZY, Zheng H, Schumpelick V, Bhardwaj RS, Klosterhalfen B (2000) Abnormal collagen I to III distribution in the skin of patients with incisional hernia. Eur Surg Res 32:43–48PubMedCrossRef Klinge U, Si ZY, Zheng H, Schumpelick V, Bhardwaj RS, Klosterhalfen B (2000) Abnormal collagen I to III distribution in the skin of patients with incisional hernia. Eur Surg Res 32:43–48PubMedCrossRef
11.
Zurück zum Zitat Bellon JM, Bajo A, Ga-Honduvilla N, Gimeno MJ, Pascual G, Guerrero A, Bujan J (2001) Fibroblasts from the transversalis fascia of young patients with direct inguinal hernias show constitutive MMP-2 overexpression. Ann Surg 233:287–291PubMedCrossRef Bellon JM, Bajo A, Ga-Honduvilla N, Gimeno MJ, Pascual G, Guerrero A, Bujan J (2001) Fibroblasts from the transversalis fascia of young patients with direct inguinal hernias show constitutive MMP-2 overexpression. Ann Surg 233:287–291PubMedCrossRef
12.
Zurück zum Zitat Klinge U, Si ZY, Zheng H, Schumpelick V, Bhardwaj RS, Klosterhalfen B (2001) Collagen I/III and matrix metalloproteinases (MMP) 1 and 13 in the fascia of patients with incisional hernias. J Invest Surg 14:47–54PubMedCrossRef Klinge U, Si ZY, Zheng H, Schumpelick V, Bhardwaj RS, Klosterhalfen B (2001) Collagen I/III and matrix metalloproteinases (MMP) 1 and 13 in the fascia of patients with incisional hernias. J Invest Surg 14:47–54PubMedCrossRef
13.
Zurück zum Zitat Si Z, Rhanjit B, Rosch R, Rene PM, Klosterhalfen B, Klinge U (2002) Impaired balance of type I and type III procollagen mRNA in cultured fibroblasts of patients with incisional hernia. Surgery 131:324–331PubMedCrossRef Si Z, Rhanjit B, Rosch R, Rene PM, Klosterhalfen B, Klinge U (2002) Impaired balance of type I and type III procollagen mRNA in cultured fibroblasts of patients with incisional hernia. Surgery 131:324–331PubMedCrossRef
14.
Zurück zum Zitat Rosch R, Junge K, Knops M, Lynen P, Klinge U, Schumpelick V (2003) Analysis of collagen-interacting proteins in patients with incisional hernias. Langenbecks Arch Surg 387:427–432PubMed Rosch R, Junge K, Knops M, Lynen P, Klinge U, Schumpelick V (2003) Analysis of collagen-interacting proteins in patients with incisional hernias. Langenbecks Arch Surg 387:427–432PubMed
15.
Zurück zum Zitat Salameh JR, Talbott LM, May W, Gosheh B, Vig PJ, McDaniel DO (2007) Role of biomarkers in incisional hernias. Am Surg 73:561–567PubMed Salameh JR, Talbott LM, May W, Gosheh B, Vig PJ, McDaniel DO (2007) Role of biomarkers in incisional hernias. Am Surg 73:561–567PubMed
16.
Zurück zum Zitat Junge K, Klinge U, Rosch R, Mertens PR, Kirch J, Klosterhalfen B, Lynen P, Schumpelick V (2004) Decreased collagen type I/III ratio in patients with recurring hernia after implantation of alloplastic prostheses. Langenbecks Arch Surg 389:17–22PubMedCrossRef Junge K, Klinge U, Rosch R, Mertens PR, Kirch J, Klosterhalfen B, Lynen P, Schumpelick V (2004) Decreased collagen type I/III ratio in patients with recurring hernia after implantation of alloplastic prostheses. Langenbecks Arch Surg 389:17–22PubMedCrossRef
17.
Zurück zum Zitat Remmele W SH (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–140PubMed Remmele W SH (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–140PubMed
18.
Zurück zum Zitat Arumugam S, Jang YC, Chen-Jensen C, Gibran NS, Isik FF (1999) Temporal activity of plasminogen activators and matrix metalloproteinases during cutaneous wound repair. Surgery 125:587–593PubMed Arumugam S, Jang YC, Chen-Jensen C, Gibran NS, Isik FF (1999) Temporal activity of plasminogen activators and matrix metalloproteinases during cutaneous wound repair. Surgery 125:587–593PubMed
19.
Zurück zum Zitat Mignatti P, Rifkin DB (1996) Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49:117–137PubMed Mignatti P, Rifkin DB (1996) Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49:117–137PubMed
20.
Zurück zum Zitat Nicholl SM, Roztocil E, Davies MG (2006) Plasminogen activator system and vascular disease. Curr Vasc Pharmacol 4:101–116PubMedCrossRef Nicholl SM, Roztocil E, Davies MG (2006) Plasminogen activator system and vascular disease. Curr Vasc Pharmacol 4:101–116PubMedCrossRef
21.
22.
Zurück zum Zitat Hu Z, Lou L, Luo S (2002) Experimental study of the expression of c-myc, c-fos and proto-oncogenes on hypertrophic and scars. Zhonghua Zheng Xing Wai Ke Za Zhi 18:165–167PubMed Hu Z, Lou L, Luo S (2002) Experimental study of the expression of c-myc, c-fos and proto-oncogenes on hypertrophic and scars. Zhonghua Zheng Xing Wai Ke Za Zhi 18:165–167PubMed
23.
Zurück zum Zitat Prendergast GC, Diamond LE, Dahl D, Cole MD (1990) The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol Cell Biol 10:1265–1269PubMed Prendergast GC, Diamond LE, Dahl D, Cole MD (1990) The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol Cell Biol 10:1265–1269PubMed
24.
Zurück zum Zitat Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M (2005) Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 167:59–69PubMed Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M (2005) Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 167:59–69PubMed
Metadaten
Titel
Analysis of c-myc, PAI-1 and uPAR in patients with incisional hernias
verfasst von
R. Rosch
M. Binnebösel
K. Junge
P. Lynen-Jansen
P. R. Mertens
U. Klinge
V. Schumpelick
Publikationsdatum
01.06.2008
Verlag
Springer-Verlag
Erschienen in
Hernia / Ausgabe 3/2008
Print ISSN: 1265-4906
Elektronische ISSN: 1248-9204
DOI
https://doi.org/10.1007/s10029-007-0311-7

Weitere Artikel der Ausgabe 3/2008

Hernia 3/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.